Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2001
11/15/2001US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001CA2408293A1 Novel vitronectin receptor antagonists
11/15/2001CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001CA2407789A1 Benzoxazines for use in the treatment of parkinson's disease
11/14/2001EP1153926A2 3,5-Dioxa-12-aza wurtzitane compound as molecular recognition agent and process of preparing same
11/14/2001EP1153100A1 Photochromatic compounds, process for their preparation and their use in polymeric materials
11/14/2001EP1153022A1 Prothease inhibitors
11/13/2001US6316618 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives
11/13/2001US6316437 Spirohydantoin compounds and uses thereof
11/13/2001US6316436 Anticancer agents
11/13/2001US6316433 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
11/13/2001US6316418 Regulated apoptosis
11/08/2001WO2001083446A1 Efficient lactam synthesis
11/08/2001US20010039274 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease
11/07/2001EP1011648B1 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/07/2001EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
11/07/2001EP0802917B1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
11/06/2001US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001US6313115 Alleviate impairment of memory, or other cognitive functions caused by hypoglutamatergic condition or by deficiency in number or strength of excitatory synapses or in number of ampa receptors
11/01/2001WO2001081352A1 Photochromatic pyrano-1,3-oxazinonaphthalene derivatives
11/01/2001WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
11/01/2001US20010037030 Tricyclic amine derivatives
11/01/2001US20010036956 Estrogen receptor modulators
10/2001
10/31/2001EP1149581A2 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/31/2001EP1149106A2 4,5-azolo-oxindoles
10/31/2001EP1149097A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
10/31/2001EP0624160B1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
10/31/2001CN1320127A New cytotoxic tris (oxazole)-containing macrolides
10/31/2001CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/31/2001CN1320123A Disubstituted maleimide compounds and medicinal utilization thereof
10/31/2001CN1320122A Pyrazole derivatives and salts thereof
10/31/2001CN1319591A Intermediate of azepine
10/30/2001CA2113189C Diaminic compounds, preparation, use and intermediates
10/25/2001WO2001079209A2 Diazafluorenone il-8 antagonists
10/25/2001WO2001079208A1 Novel azetidine derivative and process for preparation thereof
10/25/2001WO2001079195A2 Pyridine and pyrazine derivatives as thrombin inhibitors
10/25/2001WO2001023395A3 Regioselective synthesis of rapamycin derivatives
10/25/2001US20010034351 A quinazoline compound
10/25/2001US20010034350 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
10/25/2001US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001DE10020899A1 New 9-oxa-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/24/2001EP1147115A2 Tricyclic benzodiazepines as vasopressin receptor antagonists
10/24/2001EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents
10/24/2001EP0840601B1 Thip for treating sleep disorders
10/24/2001CN1073564C Photochromic spiroxazines with asymmetric monocyclic substituent, its compositions and product
10/23/2001USRE37421 Rapamycin derivatives
10/23/2001US6306892 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
10/23/2001US6306889 Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
10/23/2001US6306867 Treatment of respiratory system disorders, tumor necrosis factor and leukotrienes
10/23/2001US6306851 Cyclocarbamate and cyclic amide derivatives
10/23/2001US6306849 Selected derivatives of K-252a
10/18/2001WO2001077134A2 Process for the preparation of 6-o-propargyl erythromycin derivatives
10/18/2001WO2001077116A1 Inhibitors of prenyl-protein transferase
10/18/2001WO2001077114A1 Inhibitors of prenyl-protein transferase
10/18/2001WO2001077112A2 Photochromic spiro(indoline)naphthoxazines
10/18/2001WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001WO2001076694A1 Inhibitors of prenyl-protein transferase
10/18/2001US20010031864 Preparation of pigments
10/18/2001US20010031863 Preparing symmetrically disubstituted triphendioxazine compounds by cyclizing amino substituted benzoquinone intermediates in the presence of manganese oxide and sulfuric acid
10/18/2001US20010031761 Compounds such as camptothecin 20-o-nonanoate; antitumor agents; low toxicity; good absorbability
10/18/2001US20010031751 (+/-)-n-((1-butyl-4-piperidinyl)methyl)-3,4-dihydro-4 -hydroxy-2h-(1,3)oxazino(3,2-alpha)indole-10-carboxamide as seretonin receptor antagonist; gastrointestinal, cardiovacular and central nervous system disorders
10/17/2001EP1144411A1 Antihistaminic spiro compounds
10/17/2001EP1144395A1 2-amino-benzoxazinone derivatives for the treatment of obesity
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143977A1 2-oxy-benzoxazinone derivatives for the treatment of obesity
10/17/2001EP0834574B1 METHOD OF PURIFYING K-252a
10/17/2001EP0833818B1 3-acylindoles as cb2 receptor agonists
10/17/2001CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation
10/17/2001CN1317487A Biindolelinenaphtho-spiroxazine compound, its preparing process and products containing it
10/16/2001US6303673 Photochromic compounds
10/16/2001US6303342 Recombinant methods and materials for producing epothilones C and D
10/16/2001US6302923 Triphendioxazine compounds
10/11/2001WO2001074823A2 Fused heterocyclic derivatives, their production and use
10/11/2001WO2001074822A1 Method for the 1,3 dipolar cycloaddition of organic compounds in a microreactor
10/11/2001WO2001074774A1 Ethylenediamine derivatives
10/11/2001WO2001074760A1 Method for oximating organic carbonyl compounds and/or ch-acid compounds
10/11/2001DE10017539A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases
10/11/2001CA2405144A1 Ethylenediamine derivatives
10/11/2001CA2400858A1 Fused heterocyclic derivatives, their production and use
10/10/2001EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140877A1 Hypolipidemic and antioxidant morpholine derivatives
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140097A2 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
10/10/2001EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/10/2001EP1139755A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
10/09/2001US6300327 Neurotropin inhibitors
10/04/2001WO2001073438A1 Ricin inhibitors and methods for use thereof
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001WO2001072696A1 Arthropodicidal carboxanilides
10/04/2001WO2001019832A3 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
10/04/2001US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases
10/04/2001EP1137439A2 Stabilization of macrolides
10/04/2001EP0880528B1 Spiro-ketal derivatives and their use as therapeutic agents
10/04/2001EP0700399B1 36-derivatives of rifamycins and their use as antimicrobial agents
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 220